ARCHIVES

National Cancer Act: Early Promises Were Overstated

This article is from The Cancer Letter archive.

Vol. 24 No. 19 | May 15, 1998

Download PDF Visit The Full Archive

Related Articles

FDA Official Outlines agency’s Views On Efficacy Requirement

June 16, 1999

Gene Expression Data Posted On Web For Research Use.

March 17, 2000

In Brief: Bristol To Drop Angiostatin; Protein Fails To Meet Criteria For Development, Firm Says

February 12, 1999

Clearinghouse Funds Two Carcinogens And A Threat To Humans

March 17, 1978

AZT, DDC Combination Increase CD4 Counts, NIAID Trial Finds

January 17, 1992

Biotherapeutics Reports LAK/IL-2 Toxicity Reduced With Constant Infusion Of IL-2

April 17, 1987